2021 Form 10-K Financial Statement

#000121390022011581 Filed on March 10, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.021M $1.550M $3.660M
YoY Change 37.18% 147.3%
% of Gross Profit
Research & Development $7.571M $1.350M $2.240M
YoY Change 237.97% 135.79%
% of Gross Profit
Depreciation & Amortization $6.760K $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $12.59M $2.900M $5.910M
YoY Change 113.05% 143.21%
Operating Profit -$12.59M
YoY Change
Interest Expense $119.5K
YoY Change
% of Operating Profit
Other Income/Expense, Net $160.6K
YoY Change
Pretax Income -$12.36M -$2.900M -$5.910M
YoY Change 109.19% 143.21%
Income Tax
% Of Pretax Income
Net Earnings -$12.36M -$2.900M -$5.910M
YoY Change 109.19% 143.21%
Net Earnings / Revenue
Basic Earnings Per Share -$1.13
Diluted Earnings Per Share -$1.134M -$465.5K -$950.2K
COMMON SHARES
Basic Shares Outstanding 10.90M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.73M $19.23M $19.23M
YoY Change 267.79% 1463.41%
Cash & Equivalents $19.23M
Short-Term Investments $19.20M
Other Short-Term Assets $1.991M $1.010M $1.010M
YoY Change 97.12%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $72.72M $20.24M $20.24M
YoY Change 259.27% 1545.53%
LONG-TERM ASSETS
Property, Plant & Equipment $216.2K $20.00K $20.00K
YoY Change 980.95% 100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.018M $100.0K
YoY Change 917.89% -47.37%
Total Long-Term Assets $1.234M $120.0K $120.0K
YoY Change 928.4% -40.0%
TOTAL ASSETS
Total Short-Term Assets $72.72M $20.24M $20.24M
Total Long-Term Assets $1.234M $120.0K $120.0K
Total Assets $73.95M $20.36M $20.36M
YoY Change 263.21% 1323.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.174M $550.0K $550.0K
YoY Change 295.29% 12.24%
Accrued Expenses $152.1K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.326M $550.0K $550.0K
YoY Change 322.94% 12.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $110.0K $110.0K
YoY Change -100.0%
Other Long-Term Liabilities $52.89K
YoY Change
Total Long-Term Liabilities $52.89K $110.0K $110.0K
YoY Change -51.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.326M $550.0K $550.0K
Total Long-Term Liabilities $52.89K $110.0K $110.0K
Total Liabilities $2.379M $660.0K $660.0K
YoY Change 260.46% 34.69%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $71.57M $19.70M $19.70M
YoY Change
Total Liabilities & Shareholders Equity $73.95M $20.36M $20.36M
YoY Change 263.21% 1323.78%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$12.36M -$2.900M -$5.910M
YoY Change 109.19% 143.21%
Depreciation, Depletion And Amortization $6.760K $0.00 $0.00
YoY Change
Cash From Operating Activities -$10.59M -$1.570M -$5.650M
YoY Change 87.46% 24.6% 165.26%
INVESTING ACTIVITIES
Capital Expenditures -$15.50K -$10.00K -$20.00K
YoY Change -22.5% 0.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities -$19.52M
YoY Change
Cash From Investing Activities -$19.53M -$10.00K -$20.00K
YoY Change 97552.95% 0.0% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 63.42M -10.00K 23.66M
YoY Change 168.03% -100.93% 710.27%
NET CHANGE
Cash From Operating Activities -10.59M -1.570M -5.650M
Cash From Investing Activities -19.53M -10.00K -20.00K
Cash From Financing Activities 63.42M -10.00K 23.66M
Net Change In Cash 33.29M -1.590M 17.99M
YoY Change 85.07% 695.0% 2206.41%
FREE CASH FLOW
Cash From Operating Activities -$10.59M -$1.570M -$5.650M
Capital Expenditures -$15.50K -$10.00K -$20.00K
Free Cash Flow -$10.58M -$1.560M -$5.630M
YoY Change 87.85% 24.8% 165.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001763950
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
USD
CY2020 us-gaap Interest Income Other
InterestIncomeOther
USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
CY2020 ltrn Unrealized Gain Of Foreign Currency Translation
UnrealizedGainOfForeignCurrencyTranslation
USD
CY2020 ltrn Other Comprehensive Loss Net Of Tax
OtherComprehensiveLossNetOfTax
USD
CY2020 ltrn Common Stock Issued For Cashless Exercise Of Warrants
CommonStockIssuedForCashlessExerciseOfWarrants
USD
CY2020 ltrn Amortization Of Investment Premium
AmortizationOfInvestmentPremium
USD
CY2020 ltrn Noncash Lease Expense
NoncashLeaseExpense
USD
CY2020 ltrn Gain On Loan Forgiveness
GainOnLoanForgiveness
USD
CY2020 ltrn Loss On Investment Securities
LossOnInvestmentSecurities
USD
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
USD
CY2021 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
USD
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
USD
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
USD
CY2020 ltrn Proceeds From Repurchases Of Shares Including Commissions
ProceedsFromRepurchasesOfSharesIncludingCommissions
USD
CY2021 ltrn Proceeds From Preferred Stock Converted To Common Stock Net Of Fractional Shares Adjustment
ProceedsFromPreferredStockConvertedToCommonStockNetOfFractionalSharesAdjustment
USD
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
USD
CY2021 ltrn Borrowings On Loan Payable
BorrowingsOnLoanPayable
USD
CY2020 ltrn Effect Of Foreign Exchange Rates On Cash
EffectOfForeignExchangeRatesOnCash
USD
CY2020Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
USD
CY2021 ltrn Deferred Offering Costs Recorded In Ap And Accrued Expenses
DeferredOfferingCostsRecordedInAPAndAccruedExpenses
USD
CY2020 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
USD
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
pure
CY2020 ltrn Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodGross
shares
CY2020 ltrn Share Based Compensation Arrangements By Share Based Payment Award Options Grant In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantInPeriodWeightedAverageExercisePrice
CY2020 ltrn Stock Issued During Period Shares Stock Option Exercised
StockIssuedDuringPeriodSharesStockOptionExercised
shares
CY2020 ltrn Share Based Compensation Arrangements By Share Based Payment Award Option Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionExercisesInPeriodWeightedAverageExercisePrice
CY2020 ltrn Share Based Compensation Arrangement By Share Based Payment Award Options Expiratios In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiratiosInPeriod
shares
CY2020 ltrn Share Based Compensation Arrangements By Share Based Payment Award Options Expiration In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationInPeriodWeightedAverageExercisePrice
CY2021 ltrn Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodGross
shares
CY2021 ltrn Share Based Compensation Arrangements By Share Based Payment Award Options Grant In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantInPeriodWeightedAverageExercisePrice
CY2021 ltrn Stock Issued During Period Shares Stock Option Exercised
StockIssuedDuringPeriodSharesStockOptionExercised
shares
CY2021 ltrn Share Based Compensation Arrangements By Share Based Payment Award Option Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionExercisesInPeriodWeightedAverageExercisePrice
CY2021 ltrn Share Based Compensation Arrangement By Share Based Payment Award Options Expiratios In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiratiosInPeriod
shares
CY2021 ltrn Share Based Compensation Arrangements By Share Based Payment Award Options Expiration In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationInPeriodWeightedAverageExercisePrice
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2020Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD

Files In Submission

Name View Source Status
0001213900-22-011581-index-headers.html Edgar Link pending
0001213900-22-011581-index.html Edgar Link pending
0001213900-22-011581.txt Edgar Link pending
0001213900-22-011581-xbrl.zip Edgar Link pending
f10k2021ex21-1_lanternpharm.htm Edgar Link pending
f10k2021ex23-1_lanternpharm.htm Edgar Link pending
f10k2021ex31-1_lanternpharm.htm Edgar Link pending
f10k2021ex31-2_lanternpharm.htm Edgar Link pending
f10k2021ex32-1_lanternpharm.htm Edgar Link pending
f10k2021_lanternpharma.htm Edgar Link pending
f10k2021_lanternpharma_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
image_004.jpg Edgar Link pending
image_005.jpg Edgar Link pending
image_006.jpg Edgar Link pending
image_007.jpg Edgar Link pending
image_008.jpg Edgar Link pending
image_009.jpg Edgar Link pending
image_010.jpg Edgar Link pending
image_011.jpg Edgar Link pending
image_012.jpg Edgar Link pending
image_013.jpg Edgar Link pending
image_014.jpg Edgar Link pending
image_015.jpg Edgar Link pending
ltrn-20211231.xsd Edgar Link pending
ltrn-20211231_cal.xml Edgar Link unprocessable
ltrn-20211231_def.xml Edgar Link unprocessable
ltrn-20211231_lab.xml Edgar Link unprocessable
ltrn-20211231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending